Vaxcyte
Dan Griffin is an experienced professional in the field of chemical engineering with a focus on research and development. Currently serving as the Executive Director and Global Drug Substance Commercialization Lead at Vaxcyte since July 2024, Dan previously held multiple leadership roles at Pfizer from December 2010 to May 2024, including Associate Research Fellow and Group Leader in Bioprocess Research & Development, as well as Director of Manufacturing Science & Technology. Earlier in Dan's career, a graduate internship took place at Merck in 1998. Educationally, Dan earned both a Ph.D. and a Master's degree in Chemical Engineering from the University of Virginia, completing the Ph.D. program in December 2000 and the M.E. program in December 1998.
This person is not in any teams
This person is not in any offices
Vaxcyte
2 followers
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.